Trial intelligence / Profile preview

Amlodipine/Valsartan in Elderly Patients with Hypertension

NCT00699192Phase 3Completed

Sponsor
Novartis
Start
May 2008
Primary completion
May 2009
Modality
Small Molecules
Countries
10
01

Overview

A Phase 3 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started May 2008; status: completed.

02

Drugs

valsartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00699192.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00699192.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call